InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Steen Marten, Director. Officer active across 2 companies, notably Strongbridge Biopharma plc. Cumulatively, 4 disclosures have been recorded. History available since 14 May 2021. The latest transaction was filed on 1 October 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Marten Steen is a Director at Strongbridge Biopharma plc. He contributes to the governance of the company by participating in strategic decisions and overseeing management activities. Marten plays a key role in evaluating the company's performance and implementing best practices in governance.